Clinical Trial Update: 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression

View source ↗

Summary

A completed clinical trial evaluating the risk of suicide and depression with 5-alpha-reductase inhibitors in cases related to benign prostatic hyperplasia (BPH…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Major Depressive Disorder
• Suicide Risk

Drugs mentioned

• 5 Alpha Reductase Inhibitors

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: BPH, Depression | Status: COMPLETED | Results posted: 2018-02-05